Esperion is to acquire Corstasis Therapeutics to expand its cardiovascular franchise with the addition of Enbumyst, a ...

Partnering with a US-based CDMO can offer many advantages for pharmaceutical companies looking to the US market.

Aspire Biopharma has partnered with Microsize to advance the development of a new sublingual powder formulation of alprazolam.

New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with ...

Kairos Pharma has signed a binding agreement to acquire exclusive worldwide rights to CL-273 from Celyn Therapeutics.

BioMarin Pharmaceutical has received FDA approval for its sBLA for Palynziq’s use in adolescents aged 12 years and above with ...

The EMA's CHMP has issued a positive opinion recommending the approval of Dupixent in the EU for paediatric patients with CSU ...

Both Novo and obesity market rival Eli Lilly have outlaid significant funds to ensure future demand for oral weight loss drugs is met.

BioMarin’s Voxzogo (vosoritide) won FDA approval in paediatric achondroplasia in November 2021 and secured a label extension ...

US-based biotechnology company Rallybio has entered a definitive agreement to acquire Candid Therapeutics through a merger transaction.

This deal adds two more siRNA candidates to GSK’s pipeline, which is expanding as the company looks to offset the impact of ...